<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Bras Pneumol</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Bras Pneumol</journal-id>
      <journal-title-group>
        <journal-title>Jornal Brasileiro de Pneumologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1806-3713</issn>
      <issn pub-type="epub">1806-3756</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Pneumologia e Tisiologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26176530</article-id>
      <article-id pub-id-type="pmc">4541768</article-id>
      <article-id pub-id-type="doi">10.1590/S1806-37132015000004500</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter To The Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Pulmonary large-cell neuroendocrine carcinoma presenting as multiple cutaneous metastases</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Mestre</surname>
            <given-names>Tiago</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rodrigues</surname>
            <given-names>Ana Maria</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cardoso</surname>
            <given-names>Jorge</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1.</label>Resident in Dermatology, Department of Dermatology, Curry Cabral Hospital, Centro Hospitalar de Lisboa Central, Lisbon, Portugal</aff>
      <aff id="aff2"><label>2.</label>Senior Consultant, Department of Dermatology, Curry Cabral Hospital, Centro Hospitalar de Lisboa Central, Lisbon, Portugal</aff>
      <aff id="aff3"><label>3.</label>Head, Department of Dermatology, Curry Cabral Hospital, Centro Hospitalar de Lisboa Central, Central Lisbon Hospital Center - Lisbon, Portugal</aff>
      <pub-date pub-type="epub-ppub">
        <season>May-Jun</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>May-Jun</season>
        <year>2015</year>
      </pub-date>
      <volume>41</volume>
      <issue>3</issue>
      <fpage>289</fpage>
      <lpage>291</lpage>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>11</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>01</day>
          <month>12</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <counts>
        <fig-count count="4"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="6"/>
        <page-count count="3"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>To the Editor:</title>
      <p>Here, we describe the case of a 66-year-old, male nonsmoker with a history of type 2 diabetes mellitus, hypertension, and dyslipidemia. The patient was referred to our hospital after the emergence of four painful erythematous nodules on his face, scalp, and trunk, over a three-week period (<xref ref-type="fig" rid="f01">Figure 1</xref>). Determination of tumor markers showed elevated levels of procalcitonin (30.83 ng/mL; reference value, &lt; 0.5 ng/mL), carbohydrate antigen 19-9 (2,700 U/mL; reference value, &lt; 37 U/mL), and lactate dehydrogenase (850 U/L; reference range, 313-618 U/L). The histopathological examination of two nodules revealed strands and nests of large pleomorphic cells with vesicular nuclei and prominent nucleoli. Tumor cells were found to be immunohistochemically positive for chromogranin A, synaptophysin, and CD56 (<xref ref-type="fig" rid="f02">Figure 2</xref>), as well as for cytokeratin 7, whereas they were immunohistochemically negative for CD20. A CT scan of the chest revealed a 4-cm mass in the left lower lobe (<xref ref-type="fig" rid="f01">Figure 1</xref>). The results of a transbronchial biopsy (via bronchoscopy) confirmed the diagnostic hypothesis of large-cell neuroendocrine carcinoma (LCNEC) of the lung. The patient died three months after the diagnosis. </p>
      <p>
<fig id="f01" orientation="portrait" position="float"><label>Figure 1.</label><caption><title>Eruptive painful erythematous nodules on the face and scalp (photographs on the left). CT scans (on the right) revealed a 4-cm mass in the left lower lobe. Note the left adrenal gland metastasis (arrow).</title></caption><graphic xlink:href="1806-3713-jbpneu-41-03-00289-gf01"/></fig>
</p>
      <p>
<fig id="f02" orientation="portrait" position="float"><label>Figure 2.</label><caption><title>On the upper left, histopathological staining showing sheets of pleomorphic tumor cells with a trabecular growth pattern in the dermis (H&amp;E; magnification, &#xD7;100). Immunohistochemical staining for CD56 showed positivity for tumor cells in a cytoplasmic pattern (lower right). Tumor cells were focally positive for chromogranin (lower left) and synaptophysin (upper right).</title></caption><graphic xlink:href="1806-3713-jbpneu-41-03-00289-gf02"/></fig>
</p>
      <p>Cutaneous metastases are a sign of poor prognosis. They are the first sign of an internal malignancy in only 0.8% of cases. The neoplasms that most often present as cutaneous metastasis are breast cancer in women and lung carcinoma in men. Cutaneous metastases can have a multitude of presentations, the abdomen, chest, scalp, and face being the sites that are most often affected.<sup>(</sup>
<xref rid="B01" ref-type="bibr">1</xref>
<sup>)</sup>
</p>
      <p>Only 0.3% of all lung cancers are LCNECs, which rarely present as cutaneous metastasis. The typical LCNEC patient is a male smoker in the seventh decade of life.<sup>(</sup>
<xref rid="B02" ref-type="bibr">2</xref>
<sup>)</sup> This type of carcinoma has an aggressive course and is rapidly metastatic. However, LCNEC rarely presents as endocrine syndromes, cutaneous metastases, or involvement of the surrounding structures. It can occur in the lungs, breasts, uterine cervix, gallbladder, urinary bladder, and ovaries, as well as (rarely) in the colon.<sup>(</sup>
<xref rid="B03" ref-type="bibr">3</xref>
<sup>,</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>)</sup> There have been only four reported cases of LCNEC presenting as cutaneous metastasis, and the primary origin of the neoplasia (lung, bladder, and rectum, respectively) was identified in three of those cases.<sup>(</sup>
<xref rid="B03" ref-type="bibr">3</xref>
<sup>-</sup>
<xref rid="B05" ref-type="bibr">5</xref>
<sup>)</sup> The case in which the origin could not be identified was the only one in which multiple cutaneous metastases occurred. To our knowledge, ours is the first report of multiple cutaneous metastases as the presenting sign of LCNEC of the lung. When there is no extracutaneous involvement, excision of cutaneous metastases of LCNEC should be considered because it could increase survival. If there are internal metastases, chemotherapy should be considered the first-line treatment, albeit having been shown to elicit a weak response. Survival after cutaneous metastasis ranges from two to five months.<sup>(</sup>
<xref rid="B06" ref-type="bibr">6</xref>
<sup>)</sup> It is important to distinguish cutaneous metastases of LCNEC from Merkel cell carcinoma, a rare lesion seen mainly in areas of the skin that have been exposed to the sun.<sup>(</sup>
<xref rid="B03" ref-type="bibr">3</xref>
<sup>)</sup> In the latter, the cells are usually smaller and are cytokeratin 20-positive.<sup>(</sup>
<xref rid="B03" ref-type="bibr">3</xref>
<sup>)</sup>
</p>
      <p>The case presented here helps clarify the biological behavior and the immunohistochemical profile of LCNEC of the lung. Our findings also underscore the importance of early recognition of cutaneous metastases to the accurate diagnosis and prompt, appropriate treatment of neoplasia.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="B01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ardavanis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Orphanos</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ioannidis</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rigatos</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Skin metastases from primary lung cancer. Report of three cases and a brief review</article-title>
          <source>In Vivo</source>
          <year>2006</year>
          <volume>20</volume>
          <issue>5</issue>
          <fpage>671</fpage>
          <lpage>673</lpage>
          <pub-id pub-id-type="pmid">17091776</pub-id>
        </element-citation>
      </ref>
      <ref id="B02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gustafsson</surname>
              <given-names>BI</given-names>
            </name>
            <name>
              <surname>Kidd</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Malfertheiner</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Modlin</surname>
              <given-names>IM</given-names>
            </name>
          </person-group>
          <article-title>Bronchopulmonary neuroendocrine tumors</article-title>
          <source>Cancer</source>
          <year>2008</year>
          <volume>113</volume>
          <issue>1</issue>
          <fpage>5</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1002/cncr.23542</pub-id>
          <pub-id pub-id-type="pmid">18473355</pub-id>
        </element-citation>
      </ref>
      <ref id="B03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shin</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Oh</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>NI</given-names>
            </name>
          </person-group>
          <article-title>CK20 Positive Large-cell Neuroendocrine Carcinoma Presenting with Skin Metastases</article-title>
          <source>Ann Dermatol</source>
          <year>2011</year>
          <volume>23</volume>
          <issue>1</issue>
          <fpage>S20</fpage>
          <lpage>S24</lpage>
          <pub-id pub-id-type="doi">10.5021/ad.2011.23.S1.S20</pub-id>
          <pub-id pub-id-type="pmid">22028564</pub-id>
        </element-citation>
      </ref>
      <ref id="B04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yuan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Keating</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Farricielli</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Kuixing</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Large-cell neuroendocrine carcinoma (LCNEC) without pulmonary symptoms diagnosed in a cutaneous metastasis</article-title>
          <source>Am J Case Rep</source>
          <year>2014</year>
          <volume>15</volume>
          <fpage>97</fpage>
          <lpage>102</lpage>
          <pub-id pub-id-type="doi">10.12659/AJCR.890094</pub-id>
          <pub-id pub-id-type="pmid">24624250</pub-id>
        </element-citation>
      </ref>
      <ref id="B05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Moon</surname>
              <given-names>KC</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous metastasis from large-cell neuroendocrine carcinoma of the urinary bladder expressing CK20 and TTF-1</article-title>
          <source>Am J Dermatopathol</source>
          <year>2009</year>
          <volume>31</volume>
          <issue>2</issue>
          <fpage>166</fpage>
          <lpage>169</lpage>
          <pub-id pub-id-type="doi">10.1097/DAD.0b013e31818eba4c</pub-id>
          <pub-id pub-id-type="pmid">19318803</pub-id>
        </element-citation>
      </ref>
      <ref id="B06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beachkofsky</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Wisco</surname>
              <given-names>OJ</given-names>
            </name>
            <name>
              <surname>Osswald</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Osswald</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Hodson</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary cutaneous metastasis: a case report and review of common cutaneous metastases</article-title>
          <source>Cutis</source>
          <year>2009</year>
          <volume>84</volume>
          <issue>6</issue>
          <fpage>315</fpage>
          <lpage>322</lpage>
          <pub-id pub-id-type="pmid">20166573</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article id="S01" article-type="translation" xml:lang="pt">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Cartas Ao Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Carcinoma neuroend&#xF3;crino de grandes c&#xE9;lulas do pulm&#xE3;o diagnosticado a partir de m&#xFA;ltiplas met&#xE1;stases cut&#xE2;neas</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Mestre</surname>
            <given-names>Tiago</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rodrigues</surname>
            <given-names>Ana Maria</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cardoso</surname>
            <given-names>Jorge</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">
<sup>3</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff4"><label>1</label>Residente em Dermatologia, Departamento de Dermatologia, Hospital Curry Cabral, Centro Hospitalar de Lisboa Central, Lisboa, Portugal</aff>
      <aff id="aff5"><label>2</label>Consultora S&#xEA;nior, Departamento de Dermatologia, Hospital Curry Cabral, Centro Hospitalar de Lisboa Central, Lisboa, Portugal</aff>
      <aff id="aff6"><label>3</label>Diretor, Departamento de Dermatologia, Hospital Curry Cabral, Centro Hospitalar de Lisboa Central, Lisboa, Portugal</aff>
    </front-stub>
    <body>
      <sec>
        <title>Ao Editor:</title>
        <p>Descrevemos aqui o caso de um n&#xE3;o fumante de 66 anos de idade com hist&#xF3;ria de diabetes mellitus tipo 2, hipertens&#xE3;o e dislipidemia. O paciente foi encaminhado ao nosso hospital ap&#xF3;s o surgimento de quatro n&#xF3;dulos eritematosos dolorosos na face, couro cabeludo e tronco ao longo de um per&#xED;odo de tr&#xEA;s semanas (<xref ref-type="fig" rid="f03">Figura 1</xref>). A pesquisa de marcadores tumorais mostrou n&#xED;veis elevados de procalcitonina (30,83 ng/ml; valor de refer&#xEA;ncia, &lt; 0,5 ng/ml), ant&#xED;geno carboidrato 19-9 (2.700 U/ml; valor de refer&#xEA;ncia, &lt; 37 U/ml) e desidrogenase l&#xE1;tica (850 U/l; intervalo de refer&#xEA;ncia, 313-618 U/l). O exame histopatol&#xF3;gico dos dois n&#xF3;dulos revelou cord&#xF5;es e ninhos de grandes c&#xE9;lulas pleom&#xF3;rficas com n&#xFA;cleos vesiculares e nucl&#xE9;olos proeminentes. Na an&#xE1;lise imuno-histoqu&#xED;mica, as c&#xE9;lulas tumorais mostraram-se positivas para cromogranina A, sinaptofisina e CD56 (<xref ref-type="fig" rid="f04">Figura 2</xref>), e tamb&#xE9;m para citoqueratina 7, enquanto foram negativas para CD20. A TC de t&#xF3;rax revelou uma massa de 4 cm no lobo inferior esquerdo (<xref ref-type="fig" rid="f03">Figura 1</xref>). Os resultados da bi&#xF3;psia transbr&#xF4;nquica (por broncoscopia) confirmaram a hip&#xF3;tese diagn&#xF3;stica de carcinoma neuroend&#xF3;crino de grandes c&#xE9;lulas (CNEGC) do pulm&#xE3;o. O paciente faleceu tr&#xEA;s meses ap&#xF3;s o diagn&#xF3;stico.</p>
        <p>
<fig id="f03" orientation="portrait" position="float"><label>Figura 1.</label><caption><title>N&#xF3;dulos eritematosos dolorosos e eruptivos na face e couro cabeludo (fotografias &#xE0; esquerda). A TC de t&#xF3;rax (&#xE0; direita) revelou uma massa de 4 cm no lobo inferior esquerdo. Nota-se a presen&#xE7;a de met&#xE1;stase na gl&#xE2;ndula suprarrenal esquerda (seta).</title></caption><graphic xlink:href="1806-3713-jbpneu-41-03-00289-gf01-pt"/></fig>
</p>
        <p>
<fig id="f04" orientation="portrait" position="float"><label>Figura 2.</label><caption><title>Em cima, &#xE0; esquerda, colora&#xE7;&#xE3;o histopatol&#xF3;gica mostrando camadas de c&#xE9;lulas tumorais pleom&#xF3;rficas com padr&#xE3;o de crescimento trabecular na derme (H &amp; E; aumento, 100&#xD7;). A colora&#xE7;&#xE3;o imuno-histoqu&#xED;mica para CD56 mostrou positividade para c&#xE9;lulas tumorais em padr&#xE3;o citoplasm&#xE1;tico (embaixo, &#xE0; direita). As c&#xE9;lulas tumorais foram focalmente positivas para cromogranina (embaixo, &#xE0; esquerda) e sinaptofisina (em cima, &#xE0; direita).</title></caption><graphic xlink:href="1806-3713-jbpneu-41-03-00289-gf02-pt"/></fig>
</p>
        <p>As met&#xE1;stases cut&#xE2;neas s&#xE3;o um sinal de progn&#xF3;stico ruim. Constituem o primeiro sinal de malignidade interna em apenas 0,8% dos casos. As neoplasias que se apresentam mais frequentemente como met&#xE1;stase cut&#xE2;nea s&#xE3;o o c&#xE2;ncer de mama em mulheres e o carcinoma de pulm&#xE3;o em homens. As met&#xE1;stases cut&#xE2;neas podem ter uma multiplicidade de apresenta&#xE7;&#xF5;es, sendo que os s&#xED;tios mais frequentemente acometidos s&#xE3;o o abd&#xF4;men, o t&#xF3;rax, o couro cabeludo e a face.<sup>(</sup>
<xref rid="B01" ref-type="bibr">1</xref>
<sup>)</sup>
</p>
        <p>Apenas 0,3% de todos os c&#xE2;nceres de pulm&#xE3;o s&#xE3;o CNEGC, os quais raramente se apresentam como met&#xE1;stase cut&#xE2;nea. O t&#xED;pico paciente com CNEGC &#xE9; do sexo masculino, &#xE9; fumante e se encontra na s&#xE9;tima d&#xE9;cada de vida.<sup>(</sup>
<xref rid="B02" ref-type="bibr">2</xref>
<sup>)</sup> Esse tipo de carcinoma tem evolu&#xE7;&#xE3;o agressiva e produz met&#xE1;stases rapidamente. Por&#xE9;m, o CNEGC raramente se apresenta como s&#xED;ndromes end&#xF3;crinas, met&#xE1;stases cut&#xE2;neas ou envolvimento das estruturas vizinhas. Pode ocorrer nos pulm&#xF5;es, mamas, colo uterino, ves&#xED;cula biliar, bexiga urin&#xE1;ria e ov&#xE1;rios, e tamb&#xE9;m (raramente) no c&#xF3;lon.<sup>(</sup>
<xref rid="B03" ref-type="bibr">3</xref>
<sup>,</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>)</sup> H&#xE1; relato de apenas quatro casos de CNEGC apresentando-se como met&#xE1;stase cut&#xE2;nea, e a origem prim&#xE1;ria da neoplasia (pulm&#xE3;o, bexiga e reto, respectivamente) foi identificada em tr&#xEA;s desses casos.<sup>(</sup>
<xref rid="B03" ref-type="bibr">3</xref>
<sup>-</sup>
<xref rid="B05" ref-type="bibr">5</xref>
<sup>)</sup> O caso no qual a origem n&#xE3;o p&#xF4;de ser identificada foi o &#xFA;nico em que ocorreram m&#xFA;ltiplas met&#xE1;stases cut&#xE2;neas. At&#xE9; onde sabemos, o nosso &#xE9; o primeiro relato de m&#xFA;ltiplas met&#xE1;stases cut&#xE2;neas como sinal de apresenta&#xE7;&#xE3;o de CNEGC do pulm&#xE3;o. Quando n&#xE3;o h&#xE1; envolvimento extracut&#xE2;neo, a excis&#xE3;o de met&#xE1;stases cut&#xE2;neas de CNEGC deve ser considerada, pois poderia aumentar a sobrevida. Se h&#xE1; met&#xE1;stases internas, a quimioterapia deve ser considerada o tratamento de primeira linha, embora se tenha demonstrado que a mesma produz uma resposta fraca. A sobrevida ap&#xF3;s met&#xE1;stase cut&#xE2;nea varia de dois a cinco meses.<sup>(</sup>
<xref rid="B06" ref-type="bibr">6</xref>
<sup>)</sup> &#xC9; importante distinguir as met&#xE1;stases cut&#xE2;neas de CNEGC do carcinoma de c&#xE9;lulas de Merkel, uma les&#xE3;o rara observada principalmente em &#xE1;reas da pele que foram expostas ao sol.<sup>(</sup>
<xref rid="B03" ref-type="bibr">3</xref>
<sup>)</sup> Neste, as c&#xE9;lulas s&#xE3;o geralmente menores e s&#xE3;o positivas para citoqueratina 20.<sup>(</sup>
<xref rid="B03" ref-type="bibr">3</xref>
<sup>)</sup>
</p>
        <p>O caso aqui apresentado ajuda a esclarecer o comportamento biol&#xF3;gico e o perfil imuno-histoqu&#xED;mico do CNEGC do pulm&#xE3;o. Nossos achados tamb&#xE9;m enfatizam a import&#xE2;ncia do reconhecimento precoce das met&#xE1;stases cut&#xE2;neas para o diagn&#xF3;stico preciso e o tratamento imediato e adequado.</p>
      </sec>
    </body>
  </sub-article>
</article>
</pmc-articleset>
